Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 6, 1998, Pages 641-646

  Goldman, Steven A ^a   Baker, Evan ^a   Weyant, Robert J ^b   Clarke, Martha R ^a   Myers, Jeffrey N ^c   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CELL SURFACE MARKER;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL SUBPOPULATION; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; TONGUE CARCINOMA; TUMOR IMMUNITY;

EID: 0031777370     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.6.641     Document Type: Article

References (17)

1. Austyn JA. The dendritic cell system and anti-tumor immunity. In Vivo. 1993;7: 193-202.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
3. Rucci L, Bani B, Gallo D, Riccardi RA, Cirri MBB, Fini-Storchi O. Interdigitating cells in peritumoral infiltrate of laryngeal carcinomas: an immunocytochemical and ultrastructural study. ORL J Rhinolaryngol Relat Spec. 1991;53:349-356.
4. Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells pulsed with tumor peptides effectively treat established murine tumors. Nat Med. 1995;1:1297-1302.
5. Zeid NA, Muller HK. S-100-positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology. 1993;25:338-343.
6. Furukawa T, Shaw W, Kodama T, Sato Y, Shimosato Y, Suemasa K. T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer. 1985;56:2651-2656.
7. Ambe K, Mori M, Munetomo E. S-100 protein-positive dendritic cells in colorectal adenocarcinomas: distribution and relation to the clinical prognosis. Cancer. 1989;63:496-503.
8. Tsujitani S, Tsugio F, Tumada R, Okamura T, Yasumoto K, Sugimacni K. Langerhans cells and prognosis in patients with gastric carcinoma. Cancer. 1987;59:501-505.
9. Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinoma: immunohistochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol. 1988;89:295-300.
10. Gallo O, Bianchi S, Giannini A, Gallina E, Libonati GA, Fini-Storchi O. Correlation between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope. 1991;101:487-493.
11. Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T. Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer. 1986;57:100-105.
12. Stingl G, Katz SI, Clement L, Green I, Shevach EM. Immunologic functions of la-bearing epidermal Langerhans cells. J Immunol. 1978;121:2005-2013.
13. Rowden G, Lewis MG, Sullivan AK. la antigen expression on human epidermal Langerhans cells. Nature. 1977;268:247-248.
14. Klareskog L, Tjernlund UM, Forsum U, Peterson PA. Epidermal Langerhans cells express la antigens. Nature. 1977;268:248-250.
15. Gallo O, Libonati GA, Gallina E, et al. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1991;117: 1007-1010.
16. Modlin RL, Rowden G, Taylor CR, Phil D, Rea TH. Comparison of S-100 and OKT6 antisera in human skin. J Invest Dermatol. 1984;83:206-209.
17. Kerrebijn JD, Balm AJM, Knegt PP, Meeuwis CA, Drexhage HA. Macrophage and dendritic cell infiltration in head and neck squamous cell carcinoma: an immunohistochemical study. Cancer Immunol Immunother. 1994;38:31-37.